Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
64 Leser
Artikel bewerten:
(0)

Central DuPage Hospital Named One of the Nation's 100 Top Hospitals for the Fifth Consecutive Year

WINFIELD, Ill., March 29, 2011 /PRNewswire-USNewswire/ -- Central DuPage Hospital (CDH) in Winfield, Ill. was today named one of the nation's 100 Top Hospitals(R) by Thomson Reuters, a leading provider of information and solutions to improve the cost and quality of healthcare.

(Logo: https://photos.prnewswire.com/prnh/20100715/DC35744LOGO)

The Thomson Reuters 100 Top Hospitals(R) study evaluates performance in 10 areas: mortality; medical complications; patient safety; average patient stay; expenses; profitability; patient satisfaction; adherence to clinical standards of care; post-discharge mortality; and readmission rates for acute myocardial infarction (heart attack), heart failure, and pneumonia. The study has been conducted annually since 1993. This is thefifth consecutive time CDH has been recognized with this honor.

"The Thomson Reuters award is evidence of our commitment to those we serve," said Central DuPage Hospital's CEO, Luke McGuinness. "The members of our community know they will receive quality care and have an excellent experience at CDH. Our medical staff, nurses, employees, management team and volunteers have established a tradition of excellence that has resulted in being named a 100 Top Hospital for five consecutive years."

To conduct the 100 Top Hospitals study, Thomson Reuters researchers evaluated 2,914 short-term, acute care, non-federal hospitals. They used public information -- Medicare cost reports, Medicare Provider Analysis and Review (MedPAR) data, and core measures and patient satisfaction data from the Centers for Medicare and Medicaid Services (CMS) Hospital Compare website. Hospitals do not apply, and winners do not pay to market this honor.

The winning hospitals were announced in the March 28 edition of Modern Healthcare magazine.

"This year's 100 Top Hospitals award winners have delivered exemplary results, despite volatility from healthcare reform," said Jean Chenoweth, senior vice president at Thomson Reuters. "The leadership teams at these organizations have dealt with enormous ambiguity, yet remained focused on mission and excellence across the hospital which drove national benchmarks to new highs."

If all Medicare inpatients received the same level of care as those treated in the award-winning facilities:

--  Nearly 116,000 additional patients would survive each year.
    --  More than 197,000 patient complications would be avoided annually.
    --  Expense per adjusted discharge would drop by $462.
    --  The average patient stay would decrease by half a day.

If the same standards were applied to all inpatients, the impact would be even greater.

More information on this study and other 100 Top Hospitals research is available at www.100tophospitals.com.

About Central DuPage Hospital

Central DuPage Hospital (CDH) is a nationally recognized 313-bed facility located in Winfield, Ill., a suburb west of Chicago. CDH is a leading center for medical technology, one of the busiest surgical hospitals in Illinois and has achieved Magnet(R) recognition for excellence in nursing services.

For the last four consecutive years, Thomson Reuters has listed CDH as a 100 Top Hospital in the U.S. CDH is affiliated with other healthcare leaders, including regionally known Children's Memorial Hospital for pediatric care and, most recently, nationally known Cleveland Clinic for cardiac surgery.

Central DuPage Hospital is an interdependent network of healthcare organizations and services, including convenient care centers, occupational health services, home health and hospice care. For more information or to find a doctor on the medical staff of CDH, visit www.cdh.org or call 630-933-4234/ TTY 630-933-4833 for the hearing impaired.

Photo: https://photos.prnewswire.com/prnh/20100715/DC35744LOGO

Central DuPage Hospital

CONTACT: Amy Jo Steinbruecker, Central DuPage Hospital, +1-630-933-5117,
Amy_steinbruecker@cdh.org; or David Wilkins, Thomson Reuters,
+1-734-913-3397, david.wilkins@thomsonreuters.com

Web site: http://www.cdh.org//
http://www.100tophospitals.com//

© 2011 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.